Investing Profile

Sofia Ioannidou

InvestorVC
Partner at Andera Partners
Photo of Sofia Ioannidou, Partner at Andera Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Oxford Network
158 CONNECTIONS
UCL Network
47 CONNECTIONS
L.E.K. Consulting Network
19 CONNECTIONS
cb
$5.0M - $35.0M
$20.0M
8
CompanyStageDateRound SizeTotal Raised
Exciva
Series BJan 2026$62M
Series AOct 2021$10M
$72M
Co-investors: Raphael Wisniewski (Andera Partners), Philip Scheltens (EQT Life Sciences), Reetika Bhardwaj (ARCH Venture Partners)
Adcytherix
Series AOct 2025$120M
$160M
Co-investors: Ran Nussbaum (Pontifax Venture Capital), Ohad Hammer (Pontifax Venture Capital), Iyona Rajkomar (Pontifax Venture Capital)
Tubulis
Series COct 2025$400M
Series BMar 2024$140M
Series BMay 2022$63M
$620M
Co-investors: John de Koning (EQT Life Sciences), Sebastian Pünzeler (Coparion), Lorence Kim (Third Rock Ventures), Patrick Heron (Frazier Healthcare Partners), Nimish Shah (Venrock)
Nouscom
Series CNov 2023$73M
$140M
Co-investors: Scott Rocklage (5am Ventures), Guido Magni (Versant Ventures), Joachim Rothe (EQT Life Sciences), Genghis Lloyd-Harris (Abingworth), Hakan Goker (M Ventures (Merck))
Tricares
Series BJun 2018$26M
$26M
Co-investors: Catherine Boule (Karista), Dr. Regina Hodits (Wellington Partners)
Partner Andera PartnersPresent
Director Andera PartnersPresent
Director EdRIPPresent
Investment Director EdRIPPresent
Associate EdRIPPresent
Associate Consultant L.E.K. ConsultingPresent
Research Scientist Eyetech PharmaceuticalsPresent
University of Oxford MBiochem Biochemistry
UCL Ph.D. Cell Biology